These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 23165619)
21. Irreversible Electroporation in the Treatment of Hepatocellular Carcinoma. Lencioni R; Crocetti L; Narayanan G Tech Vasc Interv Radiol; 2015 Sep; 18(3):135-9. PubMed ID: 26365542 [TBL] [Abstract][Full Text] [Related]
22. Ablation of perivascular hepatic malignant tumors with irreversible electroporation. Kingham TP; Karkar AM; D'Angelica MI; Allen PJ; Dematteo RP; Getrajdman GI; Sofocleous CT; Solomon SB; Jarnagin WR; Fong Y J Am Coll Surg; 2012 Sep; 215(3):379-87. PubMed ID: 22704820 [TBL] [Abstract][Full Text] [Related]
23. Irreversible Electroporation of Prostate Cancer: Patient-Specific Pretreatment Simulation by Electric Field Measurement in a 3D Bioprinted Textured Prostate Cancer Model to Achieve Optimal Electroporation Parameters for Image-Guided Focal Ablation. Wendler JJ; Klink F; Seifert S; Fischbach F; Jandrig B; Porsch M; Pech M; Baumunk D; Ricke J; Schostak M; Liehr UB Cardiovasc Intervent Radiol; 2016 Nov; 39(11):1668-1671. PubMed ID: 27256102 [No Abstract] [Full Text] [Related]
24. The current role of minimally invasive therapies in the management of liver tumors. Rempp H; Boss A; Helmberger T; Pereira P Abdom Imaging; 2011 Dec; 36(6):635-47. PubMed ID: 21562884 [TBL] [Abstract][Full Text] [Related]
25. Irreversible Electroporation for Colorectal Liver Metastases. Scheffer HJ; Melenhorst MC; Echenique AM; Nielsen K; van Tilborg AA; van den Bos W; Vroomen LG; van den Tol PM; Meijerink MR Tech Vasc Interv Radiol; 2015 Sep; 18(3):159-69. PubMed ID: 26365546 [TBL] [Abstract][Full Text] [Related]
26. Low vulnerability of the right phrenic nerve to electroporation ablation. van Driel VJ; Neven K; van Wessel H; Vink A; Doevendans PA; Wittkampf FH Heart Rhythm; 2015 Aug; 12(8):1838-44. PubMed ID: 25998897 [TBL] [Abstract][Full Text] [Related]
27. Percutaneous irreversible electroporation of locally advanced pancreatic carcinoma using the dorsal approach: a case report. Scheffer HJ; Melenhorst MC; Vogel JA; van Tilborg AA; Nielsen K; Kazemier G; Meijerink MR Cardiovasc Intervent Radiol; 2015 Jun; 38(3):760-5. PubMed ID: 25288173 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of resistance as a measure of successful tumor ablation during irreversible electroporation of the pancreas. Dunki-Jacobs EM; Philips P; Martin RC J Am Coll Surg; 2014 Feb; 218(2):179-87. PubMed ID: 24315888 [TBL] [Abstract][Full Text] [Related]
29. Percutaneous radio-frequency liver tumor ablation: what are the risks? Ott DJ Am J Gastroenterol; 2003 Nov; 98(11):2564-5. PubMed ID: 14638365 [No Abstract] [Full Text] [Related]
30. In vivo results of a new focal tissue ablation technique: irreversible electroporation. Edd JF; Horowitz L; Davalos RV; Mir LM; Rubinsky B IEEE Trans Biomed Eng; 2006 Jul; 53(7):1409-15. PubMed ID: 16830945 [TBL] [Abstract][Full Text] [Related]
31. The Safety and Efficacy of Irreversible Electroporation for Large Hepatocellular Carcinoma. Zeng J; Liu G; Li ZH; Yang Y; Fang G; Li RR; Xu KC; Niu L Technol Cancer Res Treat; 2017 Feb; 16(1):120-124. PubMed ID: 27837054 [TBL] [Abstract][Full Text] [Related]
32. Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up. Dollinger M; Müller-Wille R; Zeman F; Haimerl M; Niessen C; Beyer LP; Lang SA; Teufel A; Stroszczynski C; Wiggermann P PLoS One; 2015; 10(8):e0135773. PubMed ID: 26270651 [TBL] [Abstract][Full Text] [Related]
33. Controversies between surgical and percutaneous radiofrequency ablation. Evrard S; Mathoulin-Pelissier S Eur J Surg Oncol; 2006 Feb; 32(1):3-5. PubMed ID: 16274954 [No Abstract] [Full Text] [Related]
34. Percutaneous ablation therapy of hepatocellular carcinoma with irreversible electroporation: MRI findings. Granata V; Fusco R; Catalano O; Piccirillo M; De Bellis M; Izzo F; Petrillo A AJR Am J Roentgenol; 2015 May; 204(5):1000-7. PubMed ID: 25905934 [TBL] [Abstract][Full Text] [Related]
35. Liver Function Tests Following Irreversible Electroporation of Liver Tumors: Experience in 174 Procedures. Froud T; Venkat SR; Barbery KJ; Gunjan A; Narayanan G Tech Vasc Interv Radiol; 2015 Sep; 18(3):140-6. PubMed ID: 26365543 [TBL] [Abstract][Full Text] [Related]
36. Irreversible electroporation for focal ablation at the porta hepatis. Kasivisvanathan V; Thapar A; Oskrochi Y; Picard J; Leen EL Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1531-4. PubMed ID: 22367010 [TBL] [Abstract][Full Text] [Related]
37. Percutaneous irreversible electroporation of surgically unresectable pancreatic cancer: a case report. Bagla S; Papadouris D J Vasc Interv Radiol; 2012 Jan; 23(1):142-5. PubMed ID: 22221480 [TBL] [Abstract][Full Text] [Related]
38. Percutaneous hepatic ablation: what needs to be known in 2014. Seror O Diagn Interv Imaging; 2014; 95(7-8):665-75. PubMed ID: 24776811 [TBL] [Abstract][Full Text] [Related]